Giant Cell Glioblastoma Completed Phase 1 / 2 Trials for Veliparib (DB07232)

IndicationStatusPhase
DBCOND0044206 (Giant Cell Glioblastoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01514201Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine GliomasTreatment